Skip to main content

Table 1 Patient characteristics

From: A novel model to correlate hydrogel spacer placement, perirectal space creation, and rectum dosimetry in prostate stereotactic body radiotherapy

Age ± stdev, y

69.7 ± 6.6

Range

55–82

PSA ± stdev, ng/mL

9 ± 5.3

Range

2.7–24.5

Gleason score 6 (%)

25

Gleason score 7 (%)

75

Primary GS 4 (%)

47

Cores involved ± stdev (#)

3.9 ± 2.4

Range

1–9

Cores involved ± stdev (%)

30 ± 19

Range

10–75

Clinical stage:

 cT1c

72

 cT2a

17

 cT2b

13

AUA score ± stdeva

9 ± 7

Range

0–20

SHIM score ± stdevb

14 ± 8.7

Range

0-26

Prostate volume ± stdev (cc)

40.1 ± 22.5

Range

13–108

  1. aAUA = American Urological Association Symptom Score
  2. bSHIM = Sexual Health Inventory for Men Score